GHK-Cu Research Overview: Copper Peptide Science & Published Studies

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma. It is one of the most studied peptides for gene expression modulation and extracellular matrix biology. This profile covers the published science.

Molecular Profile

Mechanism of Action (Published Research)

GHK-Cu is unique among research peptides for its documented gene expression modulation. Published studies (Pickart et al., multiple) have used genome-wide expression profiling to identify over 4,000 human genes modulated by GHK-Cu, including genes involved in collagen synthesis and ECM remodeling, antioxidant defense (SOD, glutathione), inflammatory cytokine modulation, and TGF-beta superfamily signaling.

The copper ion is essential — GHK alone (without Cu²⁺) shows significantly reduced activity in published assays. The copper complex facilitates redox chemistry and metalloenzyme activation in tissue models.

Published Research Areas

Collagen and ECM: Published studies observed upregulation of collagen I, collagen III, and decorin in fibroblast cultures. GHK-Cu is one of the most studied compounds in extracellular matrix remodeling research.

Gene expression: Broad Connectivity Map analysis (Pickart & Margolina, 2012) identified GHK as modulating a network of 4,000+ genes — an unusually large transcriptomic footprint for a tripeptide.

Antioxidant biology: Published studies observed upregulation of superoxide dismutase (SOD) and other antioxidant enzymes in cell culture models.

Tissue remodeling: Preclinical wound biology studies observed effects on fibroblast migration, angiogenesis, and glycosaminoglycan synthesis.

Research Availability

GHK-Cu is available at Pepta Labs with third-party COA. Browse the Dermatological Science category for related compounds.